Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Novanta Inc. (NASDAQ:NOVT – Get Rating) CEO Matthijs Glastra sold 6,500 shares of the stock in a transaction dated Wednesday, January 11th. The shares were sold at an average price of $145.94, for a total value of $948,610.00. Following the completion of the sale, the chief executive officer now directly owns 93,754 shares of the company’s stock, valued at approximately $13,682,458.76. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
Matthijs Glastra also recently made the following trade(s):
- On Tuesday, November 15th, Matthijs Glastra sold 20,000 shares of Novanta stock. The stock was sold at an average price of $160.06, for a total transaction of $3,201,200.00.
Novanta Stock Up 2.4 %
NOVT traded up $3.55 during mid-day trading on Friday, reaching $150.51. 84,916 shares of the stock were exchanged, compared to its average volume of 100,868. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.55 and a current ratio of 2.58. The company has a 50 day moving average price of $146.98 and a two-hundred day moving average price of $137.75. Novanta Inc. has a 1 year low of $110.84 and a 1 year high of $162.48. The stock has a market capitalization of $5.37 billion, a PE ratio of 72.39 and a beta of 1.30.
Institutional Investors Weigh In On Novanta
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. PNC Financial Services Group Inc. boosted its position in Novanta by 33.4% in the first quarter. PNC Financial Services Group Inc. now owns 3,602 shares of the technology company’s stock worth $512,000 after purchasing an additional 901 shares during the last quarter. MetLife Investment Management LLC raised its position in Novanta by 49.1% in the first quarter. MetLife Investment Management LLC now owns 18,484 shares of the technology company’s stock worth $2,630,000 after acquiring an additional 6,085 shares during the period. Raymond James Trust N.A. increased its stake in shares of Novanta by 26.5% during the 1st quarter. Raymond James Trust N.A. now owns 1,904 shares of the technology company’s stock worth $271,000 after purchasing an additional 399 shares during the last quarter. Baird Financial Group Inc. raised its holdings in shares of Novanta by 15.6% in the 1st quarter. Baird Financial Group Inc. now owns 3,090 shares of the technology company’s stock worth $440,000 after purchasing an additional 418 shares during the period. Finally, Lazard Asset Management LLC lifted its stake in Novanta by 23.1% in the first quarter. Lazard Asset Management LLC now owns 976 shares of the technology company’s stock valued at $138,000 after purchasing an additional 183 shares during the last quarter. Hedge funds and other institutional investors own 97.55% of the company’s stock.
Analyst Ratings Changes
Separately, StockNews.com assumed coverage on shares of Novanta in a report on Wednesday, October 12th. They issued a “hold” rating on the stock.
Novanta Company Profile
(Get Rating)
Novanta Inc, together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. The company's Photonics segment offers photonics-based solutions, including laser scanning and beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products serving photonics-based applications for industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures.
Featured Stories
- Get a free copy of the StockNews.com research report on Novanta (NOVT)
- JPMorgan Chase Falls As Banks Brace For Recession
- Why is the Bed Bath & Beyond Stock Price up 261%?
- Roku Stock Price is Trending, Here’s Why
- Carvana Stock Rally, Here’s What You Need to Know
- Will Oil Stocks Once Again Lead The Market As Inflation Eases?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Novanta, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Novanta wasn’t on the list.
While Novanta currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Enter your email address below and we’ll send you MarketBeat’s guide to pot stock investing and which pot companies show the most promise.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
As Featured By:
326 E 8th St #105, Sioux Falls, SD 57103
contact@marketbeat.com
(844) 978-6257
© American Consumer News, LLC dba MarketBeat® 2010-2023. All rights reserved.
© 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer.
